COVID-19: South Africa halts rollout of Oxford/AstraZeneca jab due to ‘limited protection’ as Britons face needing a third jab
South Africa is suspending its rollout of the Oxford/AstraZeneca coronavirus vaccine after findings suggested it offers limited protection against mild disease caused by the COVID-19 variant discovered there.